flutamide has been researched along with Cells, Neoplasm Circulating in 3 studies
Flutamide: An antiandrogen with about the same potency as cyproterone in rodent and canine species.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Murray, NP | 1 |
| Reyes, E | 1 |
| Fuentealba, C | 1 |
| Jacob, O | 1 |
| Orellana, N | 1 |
| Köllermann, J | 1 |
| Weikert, S | 1 |
| Schostak, M | 1 |
| Kempkensteffen, C | 1 |
| Kleinschmidt, K | 1 |
| Rau, T | 1 |
| Pantel, K | 1 |
| Fair, WR | 1 |
| Cookson, MS | 1 |
| Stroumbakis, N | 1 |
| Cohen, D | 1 |
| Aprikian, AG | 1 |
| Wang, Y | 1 |
| Russo, P | 1 |
| Soloway, SM | 1 |
| Sogani, P | 1 |
| Sheinfeld, J | 1 |
| Herr, H | 1 |
| Dalgabni, G | 1 |
| Begg, CB | 1 |
| Heston, WD | 1 |
| Reuter, VE | 1 |
1 trial available for flutamide and Cells, Neoplasm Circulating
| Article | Year |
|---|---|
The indications, rationale, and results of neoadjuvant androgen deprivation in the treatment of prostatic cancer: Memorial Sloan-Kettering Cancer Center results.
Topics: Aged; Androgen Antagonists; Antineoplastic Agents, Hormonal; Chemotherapy, Adjuvant; Drug Therapy, C | 1997 |
2 other studies available for flutamide and Cells, Neoplasm Circulating
| Article | Year |
|---|---|
Possible Role of HER-2 in the Progression of Prostate Cancer from Primary Tumor to Androgen Independence.
Topics: Age Factors; Aged; Androgen Antagonists; Antineoplastic Agents, Hormonal; Blood Vessels; Disease Pro | 2015 |
Prognostic significance of disseminated tumor cells in the bone marrow of prostate cancer patients treated with neoadjuvant hormone treatment.
Topics: Aged; Anilides; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bio | 2008 |